Results 31 to 40 of about 12,580 (199)

Angioedema after favipiravir treatment: Two cases

, 2022
Drug-induced angioedema often affects elderly patients with chronic drug use. Proper diagnosis and prompt with effective treatment reduce mortality.
Mehmet Sami Islamoglu, Mehmet Dokur, İslamoğlu, Mehmet Sami, Burak Onal, Börkü Uysal, Betül, Dokur, Mehmet, Betul Borku Uysal, Önal, Burak   +7 more
core   +1 more source

Favipiravir Tautomerism: A Short Theoretical Report

, 2020
There is no experimental data about the tautomerism of Favipiravir (T-705). Therefore its tautomeric state was predicted by using density functional theory in gas phase and in solution (toluene, acetonitrile and water).
Liudmil, Antonov, Liudmil Antonov (8700597)   +1 more
core   +1 more source

Favipiravir Pharmacokinetics in Ebola-Infected Patients of the JIKI Trial Reveals Concentrations Lower Than Targeted [PDF]

, 2017
In 2014-2015, we assessed favipiravir tolerance and efficacy in patients with Ebola virus (EBOV) disease (EVD) in Guinea (JIKI trial). Because the drug had never been used before for this indication and that high concentrations of the drugs were needed ...
Mentré, F, Pastorino, Boris, Raoul, Hervé, Anglaret, Xavier, Bore, JA, Malvy, D, France Mentré (238333), Laouénan, Cédric, Caroline Carbonnelle, Baize, Sylvain, Carbonnelle, Caroline, Xavier Anglaret, Cédric Laouénan (3776026), Anne Rodallec (3776029), Anne Rodallec, Denis Malvy, Mamoudou N. Conde (2548990), Denis Malvy (47735), Thi Huyen Tram Nguyen, Madelain, V, Anglaret, X, Nguyen, Thi Huyen Tram, Mamoudou N. Conde, Boris Pastorino, Xavier Anglaret (150373), Joseph Akoi Bore (2549020), Sissoko, Daouda, Nguyen, TH, Malvy, Denis, Madelain, Vincent, Raoul, H, Xavier de Lamballerie (95840), null null, Anne-Marie Taburet, Hervé Raoul, Vincent Madelain (3776032), Bore, Joseph Akoi, Conde, MN, Frédéric Jacquot (2825714), Pastorino, B, Anne-Marie Taburet (288246), Jean-Luc Gala, Sara Carazo (2549050), Sylvain Baize, Gala, JL, Sissoko, D, Jacquot, Frédéric, Géraldine Piorkowski (800529), Carazo, S, Mamoudou N Conde, Cédric Laouénan, Géraldine Piorkowski, Piorkowski, Géraldine, Conde, Mamoudou N, Carbonnelle, C, Xavier de Lamballerie, Daouda Sissoko (95574), France Mentré, Conde, Mamoudou, Carazo, Sara, Mentré, France, Rodallec, A, Caroline Carbonnelle (2549053), Guedj, J, Thi Huyen Tram Nguyen (3776035), Hervé Raoul (288207), de Lamballerie, X, Daouda Sissoko, Boris Pastorino (322367), Jérémie Guedj (2549236), Jean-Luc Gala (396991), Jacquot, F, Vincent Madelain, Sara Carazo, Rodallec, Anne, Taburet, Anne-Marie, de Lamballerie, Xavier, Taburet, AM, JIKI study group, Sylvain Baize (240459), Baize, S, Guedj, Jérémie, Piorkowski, G, Laouénan, C, Joseph Akoi Bore, Jérémie Guedj, Gala, Jean-Luc, Frédéric Jacquot   +87 more
core   +1 more source

Conventional and synchronous spectrofluorometric determination of the recently administered drugs for treatment of COVID-19 favipiravir and apixaban

Scientific Reports, 2022
COVID-19 is a fast-spreading pandemic that is caused by SARS-CoV-2 viral pathogen. Combination therapy of the antiviral favipiravir and the anticoagulant apixaban is one of the efficient treatment regimens.
Heba Samir Elama, Abdallah M. Zeid, Shereen M. Shalan, Yasser El-Shabrawy, Manal I. Eid   +4 more
doaj   +1 more source

Development and Validation of HPLC-UV Method for the Determination of Favipiravir in Human Plasma

Разработка и регистрация лекарственных средств, 2022
Introduction. Coronavirus disease (COVID-19) is an acute infectious disease caused by SARS-CoV-2 (severe acute respiratory syndrome-related coronavirus 2).
T. N. Komarov, P. K. Karnakova, O. A. Archakova, D. S. Shchelgacheva, N. S. Bagaeva, I. E. Shohin, K. Ya. Zaslavskaya, P. A. Bely   +7 more
doaj   +1 more source

Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis

BMC Infectious Diseases, 2021
Background Favipiravir possesses high utility for treating patients with COVID-19. However, research examining the efficacy and safety of favipiravir for patients with COVID-19 is limited.
Toshie Manabe, Dan Kambayashi, Hiroyasu Akatsu, Koichiro Kudo   +3 more
doaj   +1 more source

Follow-up of Favipiravir-Induced Nail Fluorescence: Implications for Nail and Drugs

Dermatology Practical & Conceptual, 2023
Introduction: Favipiravir creates fluorescence on nails, which can be seen with Wood's light. Objectives: The objectives of this study are to examine the properties of fluorescence in the nail due to favipiravir and to observe whether other drugs also
Hüsna Güder, Zeynep Güneş Özünal
doaj   +1 more source

Unveiling the Potential of B₃O₃ Nanoflake as Effective Transporter for the Antiviral Drug Favipiravir: Density Functional Theory Analysis

Molecules, 2023
In this study, for the first time, boron oxide nanoflake is analyzed as drug carrier for favipiravir using computational studies. The thermodynamic stability of the boron oxide and favipiravir justifies the strong interaction between both species.
Muhammad Nauman Zahid, Naveen Kosar, Hasnain Sajid, Khalid Elfaki Ibrahim, Mansour K. Gatasheh, Tariq Mahmood   +5 more
doaj   +1 more source

Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates [PDF]

, 2022
International audienceAbstract The COVID-19 pandemic has exemplified that rigorous evaluation in large animal models is key for translation from promising in vitro results to successful clinical implementation.
van der Werf, Sylvie, Ho Tsong Fang, Raphael, Contreras, Vanessa, Pizzorno, Andrés, Rosa Calatrava, Manuel, Naninck, Thibaut, Delache, Benoit, Behillil, Sylvie, Solas, Caroline, Lingas, Guillaume, Lemaitre, Julien, Kahlaoui, Nidhal, Terrier, Olivier, Ludot, Camille, Relouzat, Francis, Le Grand, Roger, Roques, Pierre, de Lamballerie, Xavier, Marlin, Romain, Maisonnasse, Pauline, Malvy, Denis, Pascal, Quentin, Nougairede, Antoine, Chapon, Catherine, Guedj, Jeremie, Dereuddre-Bosquet, Nathalie, Desjardins, Delphine   +26 more
core   +1 more source

Favipiravir-induced inflammatory and hydropic degenerative liver injury in rats

, 2023
Background. Favipiravir is very effective in the treatment of many viral infections, especially at high doses. It was used at such doses to treat coronavirus disease 2019 (COVID-19) during the pandemic.
Halis Suleyman, BİLİCİ, SAMİ, Fikret Altindag, Cebrail Gursul, SÜLEYMAN, HALİS, ÖZÇİÇEK, ADALET, Mine Gulaboglu, GÜLABOĞLU, Mine, Bulut, Seval, Durdu Altuner, Zeynep Suleyman, Altindag, Fikret, Sarigul, Cengiz, SÜLEYMAN, ZEYNEP, Seval Bulut, GÜRSUL, CEBRAİL, Sami Bilici, Altındağ, Fikret, ALTUNER, DURDU, Cengiz Sarigul, Adalet Ozcicek   +20 more
core   +1 more source